XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Summary of Significant Accounting Policies - Summary of Revenue by Category (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Disaggregation Of Revenue [Line Items]        
Revenue $ 75,659 $ 55,204 $ 140,172 $ 114,443
PGS        
Disaggregation Of Revenue [Line Items]        
Revenue 44,841 44,488 89,016 92,338
PGS | Point in Time        
Disaggregation Of Revenue [Line Items]        
Revenue 40,110 41,403 79,800 86,426
PGS | Over Time        
Disaggregation Of Revenue [Line Items]        
Revenue 4,731 3,085 9,216 5,912
Telehealth        
Disaggregation Of Revenue [Line Items]        
Revenue [1] 11,668 0 23,552 0
Telehealth | Point in Time        
Disaggregation Of Revenue [Line Items]        
Revenue [1] 9,171 0 18,532 0
Telehealth | Over Time        
Disaggregation Of Revenue [Line Items]        
Revenue [1] 2,497 0 5,020 0
Consumer services        
Disaggregation Of Revenue [Line Items]        
Revenue 56,509 44,488 112,568 92,338
Consumer services | Point in Time        
Disaggregation Of Revenue [Line Items]        
Revenue 49,281 41,403 98,332 86,426
Consumer services | Over Time        
Disaggregation Of Revenue [Line Items]        
Revenue 7,228 3,085 14,236 5,912
Research Services        
Disaggregation Of Revenue [Line Items]        
Revenue 19,150 10,716 27,604 22,105
Research Services | Point in Time        
Disaggregation Of Revenue [Line Items]        
Revenue 0 0 0 0
Research Services | Over Time        
Disaggregation Of Revenue [Line Items]        
Revenue 19,150 10,716 27,604 22,105
Service        
Disaggregation Of Revenue [Line Items]        
Revenue [2] 75,659 55,204 140,172 114,443
Service | Point in Time        
Disaggregation Of Revenue [Line Items]        
Revenue [2] 49,281 41,403 98,332 86,426
Service | Over Time        
Disaggregation Of Revenue [Line Items]        
Revenue [2] $ 26,378 $ 13,801 $ 41,840 $ 28,017
Product Concentration Risk [Member] | Revenue Benchmark [Member] | PGS        
Disaggregation Of Revenue [Line Items]        
Percentage of Revenue 60.00% 81.00% 63.00% 81.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | PGS | Point in Time        
Disaggregation Of Revenue [Line Items]        
Percentage of Revenue 53.00% 75.00% 57.00% 76.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | PGS | Over Time        
Disaggregation Of Revenue [Line Items]        
Percentage of Revenue 7.00% 6.00% 6.00% 5.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Telehealth        
Disaggregation Of Revenue [Line Items]        
Percentage of Revenue [1] 15.00% 0.00% 17.00% 0.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Telehealth | Point in Time        
Disaggregation Of Revenue [Line Items]        
Percentage of Revenue [1] 12.00% 0.00% 13.00% 0.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Telehealth | Over Time        
Disaggregation Of Revenue [Line Items]        
Percentage of Revenue [1] 3.00% 0.00% 4.00% 0.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Consumer services        
Disaggregation Of Revenue [Line Items]        
Percentage of Revenue 75.00% 81.00% 80.00% 81.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Consumer services | Point in Time        
Disaggregation Of Revenue [Line Items]        
Percentage of Revenue 65.00% 75.00% 70.00% 76.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Consumer services | Over Time        
Disaggregation Of Revenue [Line Items]        
Percentage of Revenue 10.00% 6.00% 10.00% 5.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Research Services        
Disaggregation Of Revenue [Line Items]        
Percentage of Revenue 25.00% 19.00% 20.00% 19.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Research Services | Point in Time        
Disaggregation Of Revenue [Line Items]        
Percentage of Revenue 0.00% 0.00% 0.00% 0.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Research Services | Over Time        
Disaggregation Of Revenue [Line Items]        
Percentage of Revenue 25.00% 19.00% 20.00% 19.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Service        
Disaggregation Of Revenue [Line Items]        
Percentage of Revenue [2] 100.00% 100.00% 100.00% 100.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Service | Point in Time        
Disaggregation Of Revenue [Line Items]        
Percentage of Revenue [2] 65.00% 75.00% 70.00% 76.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Service | Over Time        
Disaggregation Of Revenue [Line Items]        
Percentage of Revenue [2] 35.00% 25.00% 30.00% 24.00%
[1] There was no telehealth revenue for the three and six months ended September 30, 2021, as the Lemonaid Acquisition closed in November 2021.
[2] There was no Therapeutics revenue for the three and six months ended September 30, 2022 and 2021.